Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmunity and vascular involvement in systemic sclerosis (SSc).

M B Kahaleh1, E C LeRoy

  • 1Department of Medicine, Richard Ruppert Health Center, Medical College of Ohio, Toledo 43614-5809, USA.

Autoimmunity
|March 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between polymorphic variation in VDR and RXRA and circulating levels of vitamin D metabolites.

The Journal of steroid biochemistry and molecular biology·2010
Same author

Vascular involvement in systemic sclerosis (SSc).

Clinical and experimental rheumatology·2004
Same author

Regulation of substance P mRNA expression in human dermal microvascular endothelial cells.

Clinical and experimental rheumatology·2004
Same author

The 72-kilodalton IE-1 protein of human cytomegalovirus (HCMV) is a potent inducer of connective tissue growth factor (CTGF) in human dermal fibroblasts.

Clinical and experimental rheumatology·2004
Same author

Beauty and the beast. The nitric oxide paradox in systemic sclerosis.

Rheumatology (Oxford, England)·2002
Same author

A profibrotic polymorphism (of TGFbeta1) in systemic sclerosis.

Annals of the rheumatic diseases·2002

Scleroderma involves vascular injury and dysfunction, potentially triggered by viral infections like cytomegalovirus. Understanding these vascular changes is key to developing new scleroderma treatments.

Area of Science:

  • Rheumatology
  • Vascular Biology
  • Immunology

Background:

  • Scleroderma exhibits widespread vascular pathology, including endothelial injury and microvascular lesions.
  • This vascular damage correlates with impaired vascular function, such as increased vasospasm and reduced vasodilation.
  • Circulating vascular markers reflect the degree of endothelial injury and dysfunction.

Purpose of the Study:

  • To explore potential triggers for scleroderma-associated vascular pathology.
  • To investigate the role of viral infections, specifically cytomegalovirus (CMV), in scleroderma vasculopathy.
  • To identify key molecular signals linking vascular disease to tissue fibrosis in scleroderma.

Main Methods:

  • Review of existing literature on scleroderma vascular disease and viral infections.

Related Experiment Videos

  • Analysis of similarities between CMV vasculopathies and scleroderma vascular pathology.
  • Discussion of potential mechanisms for endothelial apoptosis in scleroderma.
  • Exploration of signaling pathways (cytokines, vascular factors, growth factors) involved in fibrosis.

    • Main Results:

    • Increased levels of anti-CMV antibodies suggest a possible link between CMV infection and scleroderma.
    • Similarities exist between CMV-induced vasculopathy and the vascular disease seen in scleroderma.
    • Endothelial apoptosis may result from viral infections, immune responses, or anti-endothelial antibodies.
    • Cytokines (e.g., TGF-beta, IL-4), endothelin, and PDGF are implicated as signals connecting vascular disease to fibrosis.

    Conclusions:

    • Viral infections, particularly CMV, are potential triggers for the vascular pathology in scleroderma.
    • Understanding the molecular links between vascular injury and fibrosis is crucial for developing targeted therapies.
    • Further research into the regulation of these signaling factors may lead to improved treatment strategies for scleroderma.